Skip to main content
AAPL+0.64%MSFT+1.07%NVDA+0.64%GOOGL+0.80%AMZN+1.46%SPCX+1.27%TSM+0.81%AVGO+3.64%META+0.81%TSLA+0.74%LLY-2.33%WMT-0.13%AMD+5.31%SKHY-0.11%JPM-1.77%BRK-B-2.07%MU+1.55%V-0.37%JNJ-2.15%XOM-3.97%MA-0.37%ASMLa+1.94%ABBV-2.33%COST-1.21%1398.HK-0.79%KO-0.71%0700.HK-6.68%CVX-4.74%PG-0.83%CSCO+2.18%0939.HK-0.05%ORCL-0.97%3988.HK-0.92%GE+0.52%BAC-1.07%HD-0.40%1816.HK-26.80%0857.HK-2.43%UNH-10.21%1288.HK-1.49%PM-0.85%0005.HK-2.03%NVS-2.46%INTC-0.91%HSBA.L-2.00%MS-1.29%AMAT+0.88%AP2d+2.23%AZN-1.93%TXN-1.16%AUDJPY-1.52%AUDUSD-1.45%AUDNZD-0.87%AUDCAD-0.87%EURAUD+0.87%AUDCHF-0.85%GBPAUD+0.80%GBPJPY-0.72%EURJPY-0.68%CHFJPY-0.67%NZDJPY-0.67%CADJPY-0.66%USDCHF+0.63%GBPUSD-0.63%USDCAD+0.59%EURUSD-0.59%NZDUSD-0.58%AUDSGD-0.50%USDZAR+0.45%AUDDKK-0.42%GBPTRY+0.41%USDTHB+0.36%AUDNOK-0.34%GBPHKD+0.32%EURZAR+0.30%NZDMXN+0.30%GBPMXN-0.28%USDMXN+0.28%GBPZAR+0.28%USDNOK+0.22%USDTRY+0.21%USDSEK+0.21%USDPLN+0.19%EURCNH-0.18%USDILS+0.16%USDDKK+0.15%EURHKD-0.15%CHFNOK+0.14%CHFSEK+0.12%USDCNH-0.11%NZDSGD+0.11%NOKJPY-0.10%USDJPY-0.09%GBPSGD-0.09%EURSGD-0.08%USDSGD+0.07%EURNOK+0.07%SGDJPY+0.06%GBPCAD-0.06%PLNJPY-0.06%EURSEK+0.06%GBPNZD-0.05%EURGBP+0.05%EURCHF+0.04%EURPLN+0.04%CADCHF+0.04%USDCOP-0.04%EURCZK+0.04%NZDCHF+0.03%EURNZD-0.02%CHFSGD-0.02%NZDCAD-0.01%EURCAD0.00%USDHKD0.00%GBPCHF0.00%EURDKK0.00%XNGUSD-0.62%XPTUSD-0.61%W1-0.42%C1-0.41%UKOIL+0.39%GAUUSD-0.32%XAUUSD-0.32%S1-0.23%XAGUSD-0.14%GAGUSD-0.14%COTTON+0.10%USOIL+0.07%BTCUSD-2.80%ETHUSD+57.77%USDTUSD-0.01%XRPUSD+52.58%SOLUSD+57.55%TRXUSDT+1.13%ZECUSDT-5.13%XMRUSDT-1.61%DOGEUSD+55.95%LINKUSD-2.46%XLMUSD-3.01%BCHUSDT-2.79%LTCUSD+47.50%UNIUSD-2.16%SUIUSD-1.92%TONUSD+59.18%HBARUSDT-4.33%TAOUSDT-1.85%AAVEUSD-2.60%ONDOUSDT-3.94%ICPUSDT-1.65%DOTUSDT-3.09%WLDUSDT-2.45%ARBUSDT-4.75%ATOMUSDT-1.71%INJUSDT-6.34%STXUSDT-0.96%PYTHUSDT+0.97%TIAUSDT-1.42%FETUSDT-3.75%JUPUSDT+2.15%SEIUSDT-2.00%GRTUSDT-2.58%OPUSDT-2.63%IOTAUSDT-1.19%POLUSDT-1.22%WIFUSDT-2.25%AXSUSDT-2.04%EOSUSDT-3.38%IMXUSDT-3.36%FARTCOINUSDT-5.08%GALAUSDT-1.65%DYDXUSDT-2.02%ORDIUSDT-1.49%NOTUSDT+0.86%RONINUSDT-2.92%AAPL+0.64%MSFT+1.07%NVDA+0.64%GOOGL+0.80%AMZN+1.46%SPCX+1.27%TSM+0.81%AVGO+3.64%META+0.81%TSLA+0.74%LLY-2.33%WMT-0.13%AMD+5.31%SKHY-0.11%JPM-1.77%BRK-B-2.07%MU+1.55%V-0.37%JNJ-2.15%XOM-3.97%MA-0.37%ASMLa+1.94%ABBV-2.33%COST-1.21%1398.HK-0.79%KO-0.71%0700.HK-6.68%CVX-4.74%PG-0.83%CSCO+2.18%0939.HK-0.05%ORCL-0.97%3988.HK-0.92%GE+0.52%BAC-1.07%HD-0.40%1816.HK-26.80%0857.HK-2.43%UNH-10.21%1288.HK-1.49%PM-0.85%0005.HK-2.03%NVS-2.46%INTC-0.91%HSBA.L-2.00%MS-1.29%AMAT+0.88%AP2d+2.23%AZN-1.93%TXN-1.16%AUDJPY-1.52%AUDUSD-1.45%AUDNZD-0.87%AUDCAD-0.87%EURAUD+0.87%AUDCHF-0.85%GBPAUD+0.80%GBPJPY-0.72%EURJPY-0.68%CHFJPY-0.67%NZDJPY-0.67%CADJPY-0.66%USDCHF+0.63%GBPUSD-0.63%USDCAD+0.59%EURUSD-0.59%NZDUSD-0.58%AUDSGD-0.50%USDZAR+0.45%AUDDKK-0.42%GBPTRY+0.41%USDTHB+0.36%AUDNOK-0.34%GBPHKD+0.32%EURZAR+0.30%NZDMXN+0.30%GBPMXN-0.28%USDMXN+0.28%GBPZAR+0.28%USDNOK+0.22%USDTRY+0.21%USDSEK+0.21%USDPLN+0.19%EURCNH-0.18%USDILS+0.16%USDDKK+0.15%EURHKD-0.15%CHFNOK+0.14%CHFSEK+0.12%USDCNH-0.11%NZDSGD+0.11%NOKJPY-0.10%USDJPY-0.09%GBPSGD-0.09%EURSGD-0.08%USDSGD+0.07%EURNOK+0.07%SGDJPY+0.06%GBPCAD-0.06%PLNJPY-0.06%EURSEK+0.06%GBPNZD-0.05%EURGBP+0.05%EURCHF+0.04%EURPLN+0.04%CADCHF+0.04%USDCOP-0.04%EURCZK+0.04%NZDCHF+0.03%EURNZD-0.02%CHFSGD-0.02%NZDCAD-0.01%EURCAD0.00%USDHKD0.00%GBPCHF0.00%EURDKK0.00%XNGUSD-0.62%XPTUSD-0.61%W1-0.42%C1-0.41%UKOIL+0.39%GAUUSD-0.32%XAUUSD-0.32%S1-0.23%XAGUSD-0.14%GAGUSD-0.14%COTTON+0.10%USOIL+0.07%BTCUSD-2.80%ETHUSD+57.77%USDTUSD-0.01%XRPUSD+52.58%SOLUSD+57.55%TRXUSDT+1.13%ZECUSDT-5.13%XMRUSDT-1.61%DOGEUSD+55.95%LINKUSD-2.46%XLMUSD-3.01%BCHUSDT-2.79%LTCUSD+47.50%UNIUSD-2.16%SUIUSD-1.92%TONUSD+59.18%HBARUSDT-4.33%TAOUSDT-1.85%AAVEUSD-2.60%ONDOUSDT-3.94%ICPUSDT-1.65%DOTUSDT-3.09%WLDUSDT-2.45%ARBUSDT-4.75%ATOMUSDT-1.71%INJUSDT-6.34%STXUSDT-0.96%PYTHUSDT+0.97%TIAUSDT-1.42%FETUSDT-3.75%JUPUSDT+2.15%SEIUSDT-2.00%GRTUSDT-2.58%OPUSDT-2.63%IOTAUSDT-1.19%POLUSDT-1.22%WIFUSDT-2.25%AXSUSDT-2.04%EOSUSDT-3.38%IMXUSDT-3.36%FARTCOINUSDT-5.08%GALAUSDT-1.65%DYDXUSDT-2.02%ORDIUSDT-1.49%NOTUSDT+0.86%RONINUSDT-2.92%
AL

Alector, Inc. (ALEC)

NASDAQ • Healthcare

$2.57
+$0 (+0.4%)
Market closed

Last close at November 18, 2026 at 21:00 UTC

Open$2.57
Day Range$2.51 - $2.74
Avg. Volume (3M)1.9M
Market Cap$382.6M
P/E Ratio7.3
52 Week Range
$1.09$2.84

Metrics Over Time

Where the Money Goes

Q3 2026
Revenueeverything earned$162.8M100%
Gross Profitminus cost of goods$162.8M100%
Operating Incomeminus R&D and overhead$123.8M76%
Net Incomeminus taxes and the rest$124.6M77%

In plain terms: out of every $100 in revenue, Alector, Inc. keeps $77 as net profit.

Fundamentals & Financials

Revenue (TTM)
$173.4M
Net Income (TTM)
$41.4M
EPS (TTM)
$0.35
ROA (TTM)
24.98%
Current Ratio
4.1

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+40.0%Q2 2026-$0.21
+8.1%Q3 2026-$0.21
+591.4%Q4 2026$1.11

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Beat +591.4%

Revenue directionally wasn’t disclosed in Alector’s preliminary third fiscal quarter of 2026 update reported November 5, 2026, but the release did provide a cash-flow snapshot, with negative operating cash flow of roughly $24.2 million as the company continues funding its immuno-neurology biotechnology pipeline. No EPS or net income figure was provided in the preliminary results, and no consensus comparison was given. Looking ahead, consensus for the next period calls for EPS of $0.29 on revenue of $77.8 million.

View full earnings history

About Alector, Inc.

Alector, Inc. is a NASDAQ-listed Biotechnology company focused on immuno-neurology, developing therapies that address immune dysfunction in degenerative brain disorders. In FY2025, it generated $21.0 million in revenue. The company works at the intersection of neuroscience and the innate immune system, aiming to change how neurodegenerative disease is treated.

Name
Alector, Inc.
CEO
Arnon Rosenthal
Industry
Healthcare
Year Founded
2013
Employees
103

Today's Snapshot

AI-generated

The day ended with ALEC slightly higher at 2.57, while its sector was weaker.

Trading Volume

Above 10d avg 2.1M

2.1M

vs S&P 500 Today

Outperforming Market

+0.65%

Updated: November 18, 2026 at 21:20 UTC

Technical Indicators

6 Buy2 Neutral0 Sell
ALEC’s technical picture supports the strong-buy stance through a mix of trend, momentum and breadth signals. The ADX reading around 28 denotes a developing directional trend while momentum indicators—CCI and MACD—are positive and RSI sits in neutral-to-favorable territory, suggesting constructive buying pressure. Price is trading above short- and medium-term moving averages and just above the classic pivot, pointing to relative strength versus the 200-day level. Volume-based OBV is supportive, even as ATR shows elevated intraday swings near 8%, implying higher volatility. Technical takeaway: trend-confirmed strength with momentum and volume alignment favors the strong-buy view.
All signals
  • EMA (5 indicators)$2.00 - $2.47
    Buy
  • RSI (14)62.64
    Neutral
  • Stochastic %K (14, 3, 3)66.67
    Neutral
  • MACD Level (12, 26)0.15
    Buy

Peers & Related Assets

FATEFate Therapeutics, Inc.
$1.05+2.9%
NKTXNkarta, Inc.
$1.15-8.0%
VORVor Biopharma Inc.
IRDOpus Genetics, Inc.
PEPGPepGen Inc.
MOLNMolecular Partners AG
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.